Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose to Present at the 2018 Global Congress on Oncology and Cancer

Jul 31, 2018 8:00am EDT

Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018

Jul 24, 2018 7:05am EDT

Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806

Jul 10, 2018 7:00am EDT

Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1x1 Day

Jul 09, 2018 7:00am EDT

FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers

Jun 29, 2018 7:00am EDT

Aptose Presents New CG-806 Data at the 23rd Congress of the European Hematology Association

Jun 15, 2018 8:00am EDT

Aptose Enters Into License Agreement With CrystalGenomics to Acquire CG-806 Rights in China

Jun 14, 2018 7:05am EDT

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

Jun 05, 2018 4:05pm EDT

Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253

Jun 04, 2018 7:04am EDT

APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC

May 31, 2018 7:04am EDT
RSS
  • Prev
    • 1...
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • ...33
    Next
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences